General Practice Doctors in Springfield, OH Accepting Medicare

7 General Practice doctors found. Showing 1 - 7

Dr. Elizabeth M Marsh, MD General Practice Medicare: Medicare Enrolled Practice Location: 30 Warder St, Suite 100, Springfield, OH 45504 Phone: 937-328-2314    Fax: 937-328-2303

George Cochran, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 E High St, Springfield, OH 45505 Phone: 937-328-8700    Fax: 397-328-8719

Sana Waikhom, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 E High St, Springfield, OH 45505 Phone: 937-328-8700    Fax: 937-328-8719

William C. Fippin, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 E High St, Springfield, OH 45505 Phone: 937-328-8700    Fax: 937-328-8719

Mr. Vipul K Patel, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 30 Warder St, Suite 100, Springfield, OH 45504 Phone: 937-328-2314    Fax: 937-328-2303

Linda S Rossel, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2230 Olympic St, Springfield, OH 45503 Phone: 937-399-4111

Dr. Robert James Scott, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 30 Warder St, Suite 100, Springfield, OH 45504 Phone: 937-328-2314    Fax: 937-328-2303

News Archive

Physician shortage could grow under new health law

HealthDay/Bloomberg BusinessWeek: With tens of millions of patients newly insured under the law, "[s]ome experts worry that there could be longer wait times to see a doctor, particularly in rural areas and underserved markets where primary-care physicians are in short supply. … [P]rimary-care physicians make up only 35 percent of America's physician workforce, and the pipeline of fresh talent is tapering off.

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma.

WIN for Asthma program improves outcomes for children with poorly controlled asthma

With childhood asthma rates in Northern Manhattan four times the national average, the Ambulatory Care Network at NewYork-Presbyterian Hospital partnered with the community of Washington Heights/Inwood to initiate the Washington-Heights Inwood Network for Asthma program. The program began in May 2006 to improve outcomes for children with poorly controlled asthma by providing culturally relevant asthma education. To date, Community Health Workers have enrolled 400 families.

Research shows why parents are born and not made

New research reveals for the first time that the different roles of mothers and fathers are influenced by genetics.

Read more Medical News

› Verified 2 days ago